Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
McKesson
Medtronic
Baxter
Boehringer Ingelheim

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Litigation Details for Apotex, Inc. v. Mylan Pharmaceuticals, Inc. (S.D. Fla. 2012)

See Plans and Pricing

« Back to Dashboard

Apotex, Inc. v. Mylan Pharmaceuticals, Inc. (S.D. Fla. 2012)

Docket   Start Trial Date Filed 2012-04-20
Court District Court, S.D. Florida Date Terminated 2013-12-02
Cause 35:0271 Patent Infringement Assigned To Patricia A. Seitz
Jury Demand Plaintiff Referred To Magistrate Judge Andrea M. Sim
Parties APOTEX CORP.; APOTEX, INC.; GREENSTONE, LLC.; LUPIN LTD.; LUPIN PHARMACEUTICALS, INC.; MYLAN PHARMACEUTICALS, INC.; PFIZER, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC.
Patents 4,344,949; 4,374,829; 4,743,450
Attorneys Aaron Stiefel; Alexander S. Lorenzo; Brett A. Hesterberg; Brian J. Prew; Brian J. Sodikoff; Christopher B. Ferenc; Christopher T. Griffith; Craig M. Kuchii; Daniel DiNapoli; David M. Hashmall; Deepro R. Mukherjee; Dennis C. Lee; Elese E. Hanson; Emer L. Simic; Eric C. Cohen; Eric David Isicoff; Frederick H. Rein; Janet T. Munn; John P. Snow; Joshua David Martin; Julia L. Kasper; Maria Josefa Beguiristain; Martin S. Masar , III; Matthew Scott Nelles; Matthew Sklar; Michael A. Dorfman; Peter H. Domer; Poopak Banky; Rachel L. Schweers; Robert Burton Breisblatt; Robert F. Green; Soumitra Deka; Stephen P. Benson; Suresh B. Pillai; Susan Virginia Warner; Sylvia M. Becker; Teresa Ragatz; Thomas J. Parker
Firms Alston & Bird LLP; Goodwin Procter, LLP, the New York Times Building; Isicoff Ragatz & Koenigsberg; Johnson & Martin, P.A.; Katten Muchin Rosenman LLP; Kaye Scholer LLP; Kaye Scholer, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Apotex, Inc. v. Mylan Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Apotex, Inc. v. Mylan Pharmaceuticals, Inc. (S.D. Fla. 2012)

Date Filed Document No. Description Snippet Link To Document
2013-08-01 137 Exhibit D - Apotex Rep. to Teva Interrog. 2 Identification Prop. Claim Terms, # 3 Exhibit C - Pat. 4,743,450, # 4 Exhibit D - Apotex Rep. to Teva Interrog.…2012 2 December 2013 0:12-cv-60704 830 Patent Plaintiff District Court, S.D External link to document
2013-08-30 148 Exhibit C- UCB, Inc. and Kremer Urban Pharmaceuticals, Inc.'s Motion to Dis of U.S. Pat. No. 4,743,450.” (‘556 patent, col. 2, ll. 16-22.) In the ‘556 patent, Apotex admits that… that U.S. Patent No. 4,743,450 (the “’450 patent”) is prior art with respect to the claimed invention… the ‘556 patent, then the patent is invalid, because, as Apotex conceded in the patent and its prosecution…hypertension medications infringe U.S. Patent No. 6,767,556 (the “’556 patent”). Apotex’s Complaint fails to…obtain the ‘556 patent, Apotex made a series of statements to the United States Patent and Trademark External link to document
2013-08-01 35 Identification Prop. Claim Terms, # 3 Exhibit C - Pat. 4,743,450, # 4 Exhibit D - Apotex Rep. to Teva Interrog.…2012 2 December 2013 0:12-cv-60704 830 Patent Plaintiff District Court, S.D External link to document
2012-09-20 38 Exhibit 1 - '486 Patent magnesium. U.S. PATENT DOCUMENTS 4,344,949 A 8/1982 Hoefle et al. …hydrochloride and disclosed in U.S. Pat. No. 4,344,949. 20 magnesium carbonate…12) United States Patent (10) Patent No.: …UNITED STATES PATENT AND TRADEMARK OFFICE CERTIFICATE OF CORRECTION PATENT NO. … appears in the above-identified patent and that said Letters Patent is hereby corrected as shown External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Baxter
McKinsey
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.